Telix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.28-$16.94 |
Market Cap | $3.7B |
Shares Short | 162,625 |
Financials
See moreRevenue (12 Mos) | $803.7M |
Revenue Growth (YoY) | 49.3% |
Gross Profit (12 Mos) | $381.8M |
Diluted EPS | -$0.02 |
News
See moreYahoo Finance • 12 days ago
FDA Alignment to Advance ProstACT Global Phase 3 Trial
Yahoo Finance • last month
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
Yahoo Finance • 2 months ago
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
About
CEO | Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., Ph.D |
Address | 55 Flemington Road, North Melbourne, VIC, Australia, 3051 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,120 |